Deciphering cell-cell communication networks to transform cancer Immunotherapy
NetwoRx Bio transforms immunotherapy success rates by deciphering the tumor microenvironment with unprecedented resolution. Its platform maps cell–cell communication across 30+ immune and stromal cell types to guide smarter cancer drug development and generate predictive biomarkers.
NetwoRx bio helps pharma and biotech companies:
- Identify optimal drug combinations, Including combinations of I/O and biological treatment.
- Discover second indications for a drug
CEO: Ori Choshen